Plk1-dependent phosphorylation of FoxM1 regulates a transcriptional programme required for mitotic progression

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Nature Cell Biology

• Publication date

  2008-08-12

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/ncb1767PMID 19160488PMCID PMC2882053
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Polo kinase controls cell-cycle-dependent transcription by targeting a coactivator protein

  2006cited by this paper
• FoxM1 is required for execution of the mitotic programme and chromosome stability

  2005cited by this paper
• Structure and function of Polo-like kinases

  2005cited by this paper
• Forkhead Box M1 Regulates the Transcriptional Network of Genes Essential for Mitotic Progression and Genes Encoding the SCF (Skp2-Cks1) Ubiquitin Ligase

  2005cited by this paper
• ON01910, a non-ATP-competitive small molecule inhibitor of Plk1, is a potent anticancer agent.

  2005cited by this paper
• Loss of the forkhead transcription factor FoxM1 causes centrosome amplification and mitotic catastrophe.

  2005cited by this paper
• Recycling the cell cycle: cyclins revisited.

  2004cited by this paper
• Polo-like kinases and the orchestration of cell division

  2004cited by this paper
• Forkhead Box M1B Transcriptional Activity Requires Binding of Cdk-Cyclin Complexes for Phosphorylation-Dependent Recruitment of p300/CBP Coactivators

  2004cited by this paper
• M-phase kinases induce phospho-dependent ubiquitination of somatic Wee1 by SCFbeta-TrCP.

  2004cited by this paper
• Plk1 regulates activation of the anaphase promoting complex by phosphorylating and triggering SCFbetaTrCP-dependent destruction of the APC Inhibitor Emi1.

  2004cited by this paper
• Identification of a Consensus Motif for Plk (Polo-like Kinase) Phosphorylation Reveals Myt1 as a Plk1 Substrate*

  2003cited by this paper
• A role for Plk1 phosphorylation of NudC in cytokinesis.

  2003cited by this paper
• The molecular basis for phosphodependent substrate targeting and regulation of Plks by the Polo-box domain.

  2003cited by this paper
• Proteomic Screen Finds pSer/pThr-Binding Domain Localizing Plk1 to Mitotic Substrates

  2003cited by this paper
• Phosphorylation of mitotic kinesin-like protein 2 by polo-like kinase 1 is required for cytokinesis

  2003cited by this paper
• Polo-like kinase 1 regulates Nlp, a centrosome protein involved in microtubule nucleation.

  2003cited by this paper
• Plk1 promotes nuclear translocation of human Cdc25C during prophase

  2002cited by this paper
• Functional studies on the role of the C-terminal domain of mammalian polo-like kinase

  2002cited by this paper
• plo1+ regulates gene transcription at the M–G1 interval during the fission yeast mitotic cell cycle

  2002cited by this paper
• Plk Phosphorylation Regulates the Microtubule-Stabilizing Protein TCTP

  2002cited by this paper
• A Spindle Checkpoint Arrest and a Cytokinesis Failure by the Dominant-negative Polo-box Domain of Plk1 in U-2 OS Cells* 210

  2002cited by this paper
• The RB and p53 pathways in cancer.

  2002cited by this paper
• Over‐expression of FoxM1 stimulates cyclin B1 expression

  2001cited by this paper
• Re-staging mitosis: a contemporary view of mitotic progression

  2001cited by this paper
• Cell division: Mitotic kinases as regulators of cell division and its checkpoints

  2001cited by this paper
• A genome-wide transcriptional analysis of the mitotic cell cycle.

  1998cited by this paper
• Animal cell cycles and their control.

  1992cited by this paper

• FOXM1 induces therapy resistance and inhibits apoptosis in a variety of human cancers

  2026influential citation
• Targeting the FOXM1/BUB1B signaling network in multiple myeloma: mechanistic insights and therapeutic potential.

  2026cites this paper
• Disruption of the FOXM1 Regulatory Region Inhibits Tumor Progression in Ovarian Cancer by CRISPR‐Cas9

  2025cites this paper
• Pan-cancer analysis of cancer-specific transcript isoforms reveals the regulatory impact of isoform switching on the alteration of the interplay between RBPs and miRNAs in cancers

  2025cites this paper
• Preparation for mitosis requires gradual CDK1 activation

  2025cites this paper
• ASPM mediates nuclear entrapment of FOXM1 via liquid-liquid phase separation to promote progression of hepatocarcinoma

  2025cites this paper
• Clinical Significance of MYBL2 Expression in Hepatocellular Carcinoma: Impact on Overall Survival

  2025influential citation
• Integrative multi-omics analysis enables a comprehensive characterization of prostate cancer and unveils metastasis-associated candidate biomarkers

  2025cites this paper
• Polo-like kinase 1 maintains transcription and chromosomal accessibility during mitosis.

  2025cites this paper
• Transcriptome Analysis of Canine Histiocytic Sarcoma Tumors and Cell Lines Reveals Multiple Targets for Therapy

  2025cites this paper
• Therapeutic targeting of endothelial calcium signaling accelerates the resolution of lung injury

  2025influential citation
• Polo‐Like Kinase 1 Expression in Colorectal Cancer: Association With RAS Mutations

  2025cites this paper
• A genetic signature predicts aggressive paraganglioma sensitivity to dual PI3K-CDK4/6 inhibition therapy

  2025influential citation
• A Wheel of Fortune: the eukaryotic cell cycle as a tetra-stable excitable system

  2025cites this paper
• REV1 Loss Triggers a G2/M Cell-Cycle Arrest Through Dysregulation of Mitotic Regulators

  2025cites this paper
• Polo-like kinase inhibitors increase AAV production by halting cell cycle progression

  2025cites this paper
• M1-NP1 interfering-peptide inhibits cancer cell proliferation and migration by targeting the transcription factor FOXM1

  2025cites this paper
• Post translational modification regulation of transcription factors governing pancreatic β-cell identity and functional mass

  2025cites this paper
• USP39 at the crossroads of cancer immunity: regulating immune evasion and immunotherapy response through RNA splicing and ubiquitin signaling

  2025cites this paper
• FOXM1 transcriptional regulation

  2024cites this paper
• Biochemical characterization of the feedforward loop between CDK1 and FOXM1 in epidermal stem cells

  2024cites this paper
• APC/C prevents a noncanonical order of cyclin/CDK activity to maintain CDK4/6 inhibitor–induced arrest

  2024cites this paper
• PLK1 and FoxM1 expressions positively correlate in papillary thyroid carcinoma and their combined inhibition results in synergistic anti‐tumor effects

  2024cites this paper
• The involvement of cyclin-dependent kinase 7 (CDK7) and 9 (CDK9) in coordinating transcription and cell cycle checkpoint regulation

  2024cites this paper
• FOXM1 c.1205 C > A mutation is associated with unilateral Moyamoya disease and inhibits angiogenesis in human brain endothelial cells

  2024cites this paper
• Identification of feature genes in intestinal epithelial cell types

  2024cites this paper
• Polo-Like Kinase 1 and DNA Damage Response

  2024cites this paper
• ABL1-mediated phosphorylation promotes FOXM1-related tumorigenicity by Increasing FOXM1 stability

  2024influential citation
• Polo-like Kinase 1 Predicts Lymph Node Metastasis in Middle Eastern Colorectal Cancer Patients; Its Inhibition Reverses 5-Fu Resistance in Colorectal Cancer Cells

  2024cites this paper
• Targeting myeloma metabolism: How abnormal metabolism contributes to multiple myeloma progression and resistance to proteasome inhibitors

  2024cites this paper
• Wee1 inhibition decouples Cdk1 and Plk1 activities: a role for gradual Cdk1 activation throughout G2 phase

  2024cites this paper
• Deletion of exons 2 and 3 from Actb and cell immortalization lead to widespread, β-actin independent alterations in gene expression associated with cell cycle control.

  2024cites this paper
• The Functional Transcriptomic Landscape Informs Therapeutic Strategies in Multiple Myeloma

  2024cites this paper
• Injury-induced Foxm1 expression in the mouse kidney drives epithelial proliferation by a cyclin F–dependent mechanism

  2024cites this paper
• The conformation of FOXM1 homodimers in vivo is crucial for regulating transcriptional activities

  2024cites this paper
• Exploring the Single‐Cell Dynamics of FOXM1 Under Cell Cycle Perturbations

  2024cites this paper
• Molecular mechanisms driving lineage plasticity in prostate cancer: NANOG and beyond

  2024cites this paper
• N-Glycoside of Indolo[2,3-a]pyrrolo[3,4-c]carbazole LCS1269 Exerts Anti-Glioblastoma Effects by G2 Cell Cycle Arrest and CDK1 Activity Modulation: Molecular Docking Studies, Biological Investigations, and ADMET Prediction

  2024cites this paper
• FOXM1 augments sorafenib resistance and promotes progression of hepatocellular carcinoma by epigenetically activating KIF23 expression.

  2023cites this paper
• Invasive FoxM1 phosphorylated by PLK1 induces the polarization of tumor-associated macrophages to promote immune escape and metastasis, amplified by IFITM1

  2023influential citation
• USP1 promotes the aerobic glycolysis and progression of T-cell acute lymphoblastic leukemia via PLK1/LDHA axis

  2023cites this paper
• Transcription factor FOXM1 specifies chromatin DNA to extracellular vesicles

  2023cites this paper
• Increased FOXM1 Expression was Associated with the Prognosis and the Recruitment of Neutrophils in Endometrial Cancer

  2023cites this paper
• A Review of the Regulatory Mechanisms of N-Myc on Cell Cycle

  2023cites this paper
• PLK1 as a cooperating partner for BCL2-mediated antiapoptotic program in leukemia

  2023cites this paper
• The Role of Polo-Like Kinase 1 in Regulating the Forkhead Box Family Transcription Factors

  2023influential citation
• PLK1 maintains DNA methylation and cell viability by regulating phosphorylation-dependent UHRF1 protein stability

  2023cites this paper
• Coordinated activation of c-Src and FOXM1 drives tumor cell proliferation and breast cancer progression

  2023cites this paper
• Transcription factor FOXM1 specifies the loading of chromatin DNA to extracellular vesicles

  2023cites this paper
• FoxM1 coordinates cell division, protein synthesis, and mitochondrial activity in a subset of β cells during acute metabolic stress.

  2023cites this paper
• Development of an interfering peptide M1-20 with potent anti-cancer effects by targeting FOXM1

  2023cites this paper
• The development of an anti-cancer peptide M1-21 targeting transcription factor FOXM1

  2023cites this paper
• FOXM1, MEK, and CDK4/6: New Targets for Malignant Peripheral Nerve Sheath Tumor Therapy

  2023cites this paper
• A co-formulation of interferons alpha2b and gamma distinctively targets cell cycle in the glioblastoma-derived cell line U-87MG

  2023cites this paper
• APC/C prevents non-canonical order of cyclin/CDK activity to maintain CDK4/6 inhibitor-induced arrest

  2023cites this paper
• Selective BD2 Inhibitor Exerts Anti-Fibrotic Effects via BRD4/FoxM1/Plk1 Axis in Orbital Fibroblasts From Patients With Thyroid Eye Disease

  2023cites this paper
• Genomic Landscape of Meningiomas.

  2023cites this paper
• Master mitotic kinases regulate viral genome delivery during papillomavirus cell entry

  2023cites this paper
• CEBP-β and PLK1 as Potential Mediators of the Breast Cancer/Obesity Crosstalk: In Vitro and In Silico Analyses

  2023cites this paper
• HMGA1 and FOXM1 Cooperate to Promote G2/M Cell Cycle Progression in Cancer Cells

  2023cites this paper
• Inhibition of USP7 induces p53-independent tumor growth suppression in triple-negative breast cancers by destabilizing FOXM1

  2023cites this paper
• FOXM1: A small fox that makes more tracks for cancer progression and metastasis.

  2023cites this paper
• Postmitotic G1 phase survivin drives mitogen-independent cell division of B lymphocytes

  2022cites this paper
• Recent Progress on the Localization of PLK1 to the Kinetochore and Its Role in Mitosis

  2022cites this paper
• Phosphorylation-Dependent Regulation of WNT/Beta-Catenin Signaling

  2022cites this paper
• Pan-Cancer Transcriptomic Analysis Identifies PLK1 Crucial for the Tumorigenesis of Clear Cell Renal Cell Carcinoma

  2022cites this paper
• Expression of FOXM1 and PLK1 predicts prognosis of patients with hepatocellular carcinoma

  2022cites this paper
• Par-4 in Cell Cycle Regulation

  2022cites this paper
• Structure and function of MuvB complexes

  2022cites this paper
• A review of Plks: Thinking outside the (polo) box

  2022cites this paper
• Cyclin-dependent kinase-mediated phosphorylation and the negative regulatory domain of transcription factor B-Myb modulate its DNA binding

  2022cites this paper
• Impairment of FOXM1 expression in mesenchymal cells from patients with myeloid neoplasms, de novo and therapy-related, may compromise their ability to support hematopoiesis

  2022influential citation
• The initiation of mammalian embryonic transcription: to begin at the beginning.

  2022cites this paper
• Targeting the Complex Protein Network of MYCN-amplified Anaplastic Ependymoma: A Case Report

  2022cites this paper
• Transcriptomic and Functional Evidence for Differential Effects of MCF-7 Breast Cancer Cell-Secretome on Vascular and Lymphatic Endothelial Cell Growth

  2022cites this paper
• E2F2 promotes lung adenocarcinoma progression through B-Myb- and FOXM1-facilitated core transcription regulatory circuitry

  2022cites this paper
• Exogenous proline enhances susceptibility of NSCLC to cisplatin via metabolic reprogramming and PLK1-mediated cell cycle arrest

  2022cites this paper
• Hepatocellular carcinoma evades RB1-induced senescence by activating the FOXM1–FOXO1 axis

  2022influential citation
• SETD3 Methyltransferase Regulates PLK1 Expression to Promote In Situ Hepatic Carcinogenesis

  2022cites this paper
• Distinct Roles of NANOS1 and NANOS3 in the Cell Cycle and NANOS3-PUM1-FOXM1 Axis to Control G2/M Phase in a Human Primordial Germ Cell Model

  2022cites this paper
• B-Myb association with DNA is mediated by its negative regulatory domain and Cdk phosphorylation

  2022cites this paper
• Targeting TACC3 represents a novel vulnerability in highly aggressive breast cancers with centrosome amplification

  2022cites this paper
• Advances in Molecular Biological and Translational Studies in World Health Organization Grades 2 and 3 Meningiomas: A Literature Review

  2022cites this paper
• Cucurbitacin B-induced G2/M cell cycle arrest of conjunctival melanoma cells mediated by GRP78–FOXM1–KIF20A pathway

  2022cites this paper
• Transcriptional repression by FoxM1 suppresses tumor differentiation and promotes metastasis of breast cancer.

  2022cites this paper
• Present and Future Perspective on PLK1 Inhibition in Cancer Treatment

  2022cites this paper
• FOXM1 and Cancer: Faulty Cellular Signaling Derails Homeostasis

  2021cites this paper
• MMB-FOXM1-driven premature mitosis is required for CHK1 inhibitor sensitivity

  2021cites this paper
• DNA damage response proteins synergistically affect the cancer prognosis and resistance.

  2021cites this paper
• Synergistic Therapy for Cervical Cancer by Codelivery of Cisplatin and JQ1 Inhibiting Plk1-Mutant Trp53 Axis.

  2021cites this paper
• Histone Deacetylase Inhibitor-Induced CDKN2B and CDKN2D Contribute to G2/M Cell Cycle Arrest Incurred by Oxidative Stress in Hepatocellular Carcinoma Cells via Forkhead Box M1 Suppression

  2021cites this paper
• CXCR4 hyperactivation cooperates with TCL1 in CLL development and aggressiveness

  2021cites this paper
• Forkhead Box Protein M1 Promotes Nasopharyngeal Carcinoma Cell Tumorigenesis Possibly via the Wnt/β-Catenin Signaling Pathway

  2021cites this paper
• Supplemental Materials

  2021cites this paper
• Hub Gene Identi cation and Prognostic Model Establishment for Patients with HBV-related Hepatocellular Carcinoma

  2021cites this paper
• Modelling the Functions of Polo-Like Kinases in Mice and Their Applications as Cancer Targets with a Special Focus on Ovarian Cancer

  2021cites this paper
• FOXM1: A Multifunctional Oncoprotein and Emerging Therapeutic Target in Ovarian Cancer

  2021cites this paper
• CDC2 Is an Important Driver of Vascular Smooth Muscle Cell Proliferation via FOXM1 and PLK1 in Pulmonary Arterial Hypertension

  2021influential citation
• A modular approach for modeling the cell cycle based on functional response curves

  2021cites this paper
• Molecular targets and therapeutics in chemoresistance of triple-negative breast cancer

  2021cites this paper